Skip to main content

Advertisement

SpringerLink
Log in

Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature

  • Letter to the Editor
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Johnson-Coyle L, Jensen L, Sobey A, American College of Cardiology Foundation, American Heart Association (2012) Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care 21:89–98

    Article  PubMed  Google Scholar 

  2. Karaye KM, Henein MY (2013) Peripartum cardiomyopathy: a review article. Int J Cardiol 164:33–38

    Article  PubMed  Google Scholar 

  3. Harper MA, Meyer RE, Berg CJ (2012) Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol 120:1013–1019

    PubMed  Google Scholar 

  4. Courand PY, Jenck S, Cassar E, David E, Carrabin N, Lantelme P (2012) Takotsubo cardiomyopathy probably associated with administration of sulprostone following cesarean delivery. Rev Esp Cardiol 65:770–771

    Article  PubMed  Google Scholar 

  5. Chen FG, Koh KF, Chong YS (1998) Cardiac arrest associated with sulprostone use during caesarean section. Anaesth Intensive Care 26:298–301

    PubMed  CAS  Google Scholar 

  6. Sung CW, Jung JH, Lee SH et al (2009) Acute myocardial infarction due to vasospasm induced by prostaglandin. Can J Cardiol 25:e359–e360

    Article  PubMed  Google Scholar 

  7. Jo YY, Park S, Choi YS (2011) Extracorporeal membrane oxygenation in a patient with stress-induced cardiomyopathy after caesarean section. Anaesth Intensive Care 39:947–954

    Google Scholar 

  8. Bosch MG, Santema JG, van der Voort PH, Bams JL (2008) A serious complication in the puerperium: peripartum cardiomyopathy. Neth Heart J 16:415–418

    Article  PubMed  CAS  Google Scholar 

  9. Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group (2011) Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. Obstet Gynecol 118(2 Pt 1):257–265

Download references

Conflict of interest

All authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, 85000, La Roche sur Yon, France

    Mathilde Vital & Guillaume Ducarme

  2. Medical–Surgical Intensive Care Unit, Centre Hospitalier Departemental, La Roche sur Yon, France

    Christine Lebert & Jean Reignier

Authors
  1. Mathilde Vital
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Lebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Reignier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guillaume Ducarme
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guillaume Ducarme.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vital, M., Lebert, C., Reignier, J. et al. Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature. Arch Gynecol Obstet 288, 1423–1424 (2013). https://doi.org/10.1007/s00404-013-2905-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-2905-x

Keywords

Search

Navigation